MARQIBO KIT Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Marqibo Kit, and when can generic versions of Marqibo Kit launch?
Marqibo Kit is a drug marketed by Acrotech and is included in one NDA.
The generic ingredient in MARQIBO KIT is vincristine sulfate. There are thirteen drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the vincristine sulfate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for MARQIBO KIT?
- What are the global sales for MARQIBO KIT?
- What is Average Wholesale Price for MARQIBO KIT?
Summary for MARQIBO KIT
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 48 |
Clinical Trials: | 30 |
Patent Applications: | 2,873 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for MARQIBO KIT |
DailyMed Link: | MARQIBO KIT at DailyMed |
![MARQIBO KIT drug patent expirations Drug patent expirations by year for MARQIBO KIT](/p/graph/s/t/MARQIBO_KIT-patent-expirations.png)
![Drug Prices for MARQIBO KIT](/p/graph/drug-price/MARQIBO+KIT.png)
Recent Clinical Trials for MARQIBO KIT
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Medical College of Wisconsin | Phase 1 |
Amgen | Phase 2 |
Dorothy Sipkins, MD, PhD | Phase 2 |
US Patents and Regulatory Information for MARQIBO KIT
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Acrotech | MARQIBO KIT | vincristine sulfate | INJECTABLE, LIPOSOMAL;INTRAVENOUS | 202497-001 | Aug 9, 2012 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for MARQIBO KIT
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Acrotech | MARQIBO KIT | vincristine sulfate | INJECTABLE, LIPOSOMAL;INTRAVENOUS | 202497-001 | Aug 9, 2012 | ⤷ Sign Up | ⤷ Sign Up |
Acrotech | MARQIBO KIT | vincristine sulfate | INJECTABLE, LIPOSOMAL;INTRAVENOUS | 202497-001 | Aug 9, 2012 | ⤷ Sign Up | ⤷ Sign Up |
Acrotech | MARQIBO KIT | vincristine sulfate | INJECTABLE, LIPOSOMAL;INTRAVENOUS | 202497-001 | Aug 9, 2012 | ⤷ Sign Up | ⤷ Sign Up |
Acrotech | MARQIBO KIT | vincristine sulfate | INJECTABLE, LIPOSOMAL;INTRAVENOUS | 202497-001 | Aug 9, 2012 | ⤷ Sign Up | ⤷ Sign Up |
Acrotech | MARQIBO KIT | vincristine sulfate | INJECTABLE, LIPOSOMAL;INTRAVENOUS | 202497-001 | Aug 9, 2012 | ⤷ Sign Up | ⤷ Sign Up |
Acrotech | MARQIBO KIT | vincristine sulfate | INJECTABLE, LIPOSOMAL;INTRAVENOUS | 202497-001 | Aug 9, 2012 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for MARQIBO KIT
See the table below for patents covering MARQIBO KIT around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Canada | 2412790 | MEDICAMENTS ANTINEOPLASIQUES LIPOSOMAUX ET LEURS UTILISATIONS (LIPOSOMAL ANTINEOPLASTIC DRUGS AND USES THEREOF) | ⤷ Sign Up |
Australia | 2709495 | ⤷ Sign Up | |
Germany | 60115044 | ⤷ Sign Up | |
World Intellectual Property Organization (WIPO) | 0202078 | ⤷ Sign Up | |
Brazil | PI0009448 | kit para uso no tratamento de uma neoplasia em um mamÃfero | ⤷ Sign Up |
European Patent Office | 1299085 | COMPOSITIONS AMELIOREES DE CAMPTOTHECINES DANS DES LIPOSOMES ET LEURS APPLICATIONS (IMPROVED LIPOSOMAL CAMPTOTHECINS AND USES THEREOF) | ⤷ Sign Up |
Japan | H10501534 | ⤷ Sign Up | |
>Country | >Patent Number | >Title | >Estimated Expiration |